Therapeutic method
AssigneeAuckland Uniservices Limited
InventorsIan Reginald Reid, Jillian Cornish
Life of this patent
Estimating the term…
Abstract
The present invention relates to new therapeutic use of amylin as agent which stimulates chondrocyte proliferation and which therefore have utility in the treatment of cartilage disorders and/or cartilage mediated bone growth.
Claims5
A method of treating a patient to stimulate chondrocyte proliferation in vivo which comprises the step of increasing amylin activity within said patient by an amount effective to stimulate chondrocyte proliferation.
A method of treating a patient to stimulate cartilage growth or repair in vivo through stimulation of chondrocyte proliferation which comprises the step of increasing amylin activity within said patient by an amount effective to stimulate chondrocyte proliferation.
A method of treating a patient to stimulate chondrocyte proliferation in vivo which comprises the step of administering to said patient amylin or an analog thereof in an amount effective to stimulate chondrocyte proliferation, the amylin analog being a fragment of amylin comprising amylin (1-8) (SEQ ID NO:2).
A method of treating a patient to stimulate cartilage growth or repair in vivo through stimulation of chondrocyte proliferation which comprises the step of administering to said patient amylin or an analog thereof in an amount effective to stimulate chondrocyte proliferation, the amylin analog being, a fragment of amylin comprising amylin (1-8) (SEQ ID NO:2).
A method of stimulating chondrocyte proliferation in vitro which comprises administering an amount of amylin or an analog of amylin to said chondrocytes is in an amount effective in inducing chondrocyte proliferation, the amylin being a fragment of amylin comprising amylin (1-8).
Dependencies are inferred from the claim text.